Advertisement
*
Reproduction permitted for personal use only. For reprints and reprint permission, contact reprints@wistechnology.com.

Milwaukee's PointOne appoints new president and CEO

MILWAUKEE -- PointOne Systems, a company specializing in patient-specific molecular data and personalized medicine, has chosen Frank Langely as its president and chief executive officer, it announced Friday.

Langely most recently served as president and CEO of Pel-Freez Clinical Systems, located in Brown Deer. The company develops molecular biology and serologic products for solid organ and bone marrow transplants and experienced significant growth and eventual acquisition under Langely's leadership.

Langely currently serves on the boards of the Medical College of Wisconsin Research Foundation as well as the Wisconsin Biotechnology and Medical Device Association. He was also a former president of the Biotech Association.

“Frank is a timely addition to PointOne. His experience and knowledge of the biotech and health care sectors will accelerate the commercialization of our molecular medicine software platforms and services for the health care industry,” Peter J. Tonellato, founder and chairman of PointOne.

Langley succeeds Dr. Drew Palin, who led PointOne for its first three years, managing the development of PointOne's Genomic Clinical System platform for use by hospitals in providing molecular medicine at the point of care.

The company will continue to build upon its collaboration with Aurora Health Care to develop its next generation of molecular medicine products. One facet of this relationship focuses on the personalized medical care model that two million Aurora patients have utilized. Aurora Health Care is a not-for-profit Wisconsin health care provider.

Comments

Dr.Batool M. Mahdi responded 4 years ago: #1

Dear Dr.
Frank Langle is a very nice personality and very good manager,I met him in 2001 and I appreciate and thanks his help and kindness in training me and understanding the molecular method in tissue typing especially RSCA . He help me very much, he made many progress in the company and the company develops molecular biology and serologic products for solid organ and bone marrow transplants and experienced significant growth and eventual acquisition under Langely's leadership.We use the product of the his company for many years and proved its very good and excellent quality, I hope to send me his e-mail. Lastly, I hope to see Frank at the top always and in more progress.with regard to him and to you

-Add Your Comment

Name:
E-mail:

Comment Policy: WTN News accepts comments that are on-topic and do not contain advertisements, profanity or personal attacks. Comments represent the views of the individuals who post them and do not necessarily represent the views of WTN Media or our partners, advertisers, or sources. Comments are moderated and are not immediately posted. Your email address will not be posted.

WTN Media cannot accept liability for the content of comments posted here or verify their accuracy. If you believe this comment section is being abused, contact edit@wistechnology.com.

WTN Media Presents